Product Information
MARLISSA-28 TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1125 per EA under NDC 68462038829. Its NADAC has been published 657 times since Nov 28, 2013.
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462038829
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091452On Market Since
2/29/2012
Price Statistics
The NADAC for MARLISSA-28 TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 82.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1125 per EA |
|---|---|
| All-time high | $0.6294 (Dec 11, 2013) |
| All-time low | $0.0800 (Nov 20, 2024) |
| 52-week high | $0.1210 |
| 52-week low | $0.1101 |
| Median price | $0.2350 |
| Average price | $0.2867 |
| Largest weekly change | +72.0% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MARLISSA-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MARLISSA-28 TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1125 per EA (NDC 68462038829), effective Jun 24, 2026.
How has the price of MARLISSA-28 TABLET changed over time?
Over the history we have for it, the NADAC for MARLISSA-28 TABLET has declined 82.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MARLISSA-28 TABLET?
Since Nov 28, 2013, the NADAC for MARLISSA-28 TABLET has ranged from a low of $0.0800 (Nov 20, 2024) to a high of $0.6294 (Dec 11, 2013), with a median of $0.2350 per EA.
Are there cheaper alternatives to MARLISSA-28 TABLET?
8 NADAC-published products share the same active ingredient, strength, and dosage form as MARLISSA-28 TABLET, but none are currently priced below it.
Who manufactures MARLISSA-28 TABLET?
MARLISSA-28 TABLET (NDC 68462038829) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification